Everhart Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $322K | Sell |
793
-1,309
| -62% | -$531K | 0.04% | 281 |
|
2025
Q1 | $1.05M | Buy |
2,102
+999
| +91% | +$497K | 0.14% | 103 |
|
2024
Q4 | $574K | Sell |
1,103
-953
| -46% | -$496K | 0.12% | 169 |
|
2024
Q3 | $1.27M | Buy |
2,056
+464
| +29% | +$287K | 0.28% | 68 |
|
2024
Q2 | $880K | Buy |
1,592
+320
| +25% | +$177K | 0.23% | 93 |
|
2024
Q1 | $739K | Buy |
1,272
+836
| +192% | +$486K | 0.22% | 97 |
|
2023
Q4 | $231K | Sell |
436
-312
| -42% | -$166K | 0.08% | 217 |
|
2023
Q3 | $379K | Buy |
748
+38
| +5% | +$19.2K | 0.16% | 122 |
|
2023
Q2 | $370K | Sell |
710
-537
| -43% | -$280K | 0.15% | 129 |
|
2023
Q1 | $719K | Buy |
1,247
+192
| +18% | +$111K | 0.32% | 61 |
|
2022
Q4 | $581K | Sell |
1,055
-206
| -16% | -$113K | 0.29% | 76 |
|
2022
Q3 | $640K | Buy |
1,261
+166
| +15% | +$84.3K | 0.35% | 54 |
|
2022
Q2 | $595K | Buy |
1,095
+224
| +26% | +$122K | 0.36% | 59 |
|
2022
Q1 | $515K | Buy |
871
+218
| +33% | +$129K | 0.3% | 73 |
|
2021
Q4 | $436K | Buy |
+653
| New | +$436K | 0.26% | 72 |
|